1. Home
  2. NLSP vs HOLO Comparison

NLSP vs HOLO Comparison

Compare NLSP & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • HOLO
  • Stock Information
  • Founded
  • NLSP 2015
  • HOLO 2018
  • Country
  • NLSP Switzerland
  • HOLO China
  • Employees
  • NLSP N/A
  • HOLO N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • NLSP Health Care
  • HOLO Technology
  • Exchange
  • NLSP Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • NLSP 12.4M
  • HOLO 24.9M
  • IPO Year
  • NLSP 2021
  • HOLO N/A
  • Fundamental
  • Price
  • NLSP $2.44
  • HOLO $5.08
  • Analyst Decision
  • NLSP
  • HOLO
  • Analyst Count
  • NLSP 0
  • HOLO 0
  • Target Price
  • NLSP N/A
  • HOLO N/A
  • AVG Volume (30 Days)
  • NLSP 407.1K
  • HOLO 1.9M
  • Earning Date
  • NLSP 07-15-2025
  • HOLO 01-01-0001
  • Dividend Yield
  • NLSP N/A
  • HOLO N/A
  • EPS Growth
  • NLSP N/A
  • HOLO N/A
  • EPS
  • NLSP N/A
  • HOLO N/A
  • Revenue
  • NLSP N/A
  • HOLO $39,771,750.00
  • Revenue This Year
  • NLSP N/A
  • HOLO N/A
  • Revenue Next Year
  • NLSP N/A
  • HOLO N/A
  • P/E Ratio
  • NLSP N/A
  • HOLO N/A
  • Revenue Growth
  • NLSP N/A
  • HOLO 42.62
  • 52 Week Low
  • NLSP $1.30
  • HOLO $4.16
  • 52 Week High
  • NLSP $15.59
  • HOLO $780.00
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 52.64
  • HOLO 42.88
  • Support Level
  • NLSP $2.16
  • HOLO $4.65
  • Resistance Level
  • NLSP $3.08
  • HOLO $5.17
  • Average True Range (ATR)
  • NLSP 0.24
  • HOLO 0.37
  • MACD
  • NLSP -0.00
  • HOLO 0.34
  • Stochastic Oscillator
  • NLSP 30.21
  • HOLO 73.02

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

Share on Social Networks: